Vera Therapeutics, Inc.

VERA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$80-$77-$52-$43
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$10$9$8$6
Change in WC$9$13-$9-$1
Other Non-Cash-$0-$1-$1-$1
Operating Cash Flow-$62-$55-$54-$39
Investing Activities
PP&E Inv.-$0-$0-$0-$1
Net Acquisitions$0$0$0$0
Inv. Purchases-$99-$95-$90-$294
Inv. Sales/Matur.$169$126$106$73
Other Inv. Act.$0-$3-$1$0
Investing Cash Flow$70$29$15-$221
Financing Activities
Debt Repay.$0$20$0$0
Stock Issued$0$0$0$345
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1$0$2-$19
Financing Cash Flow$1$20$2$326
Forex Effect$0$0$0$0
Net Chg. in Cash$9-$6-$38$65
Supplemental Information
Beg. Cash$49$55$93$27
End Cash$58$49$55$93
Free Cash Flow-$62-$55-$55-$40